Discovery Life Sciences is a global market leader in bio-specimen analysis and characterization for the pharmaceutical, biotechnology, and diagnostics industries. With a particular emphasis in oncology; cardiology; neurology; and infectious, inflammatory, and autoimmune diseases, the company operates through a global, integrated network of more than 165 clinical sources, in 25 countries on six continents.

A leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market, specializing in lateral flow point-of-care testing.

CRISPR gene editing design software and services.

North American Sales Leader for RNAi and CRISPR gene editing technology for Dharmacon unit divested to GE by ThermoFisher Scientific. Now part of Horizon Discovery.

Sales Leader for RNAi, qPCR, and molecular biology products. Managed 10 Technical Sales Specialists covering 20 states, and coordinated multiple distribution channels.

Responsible for delivering financial results for key division of publicly traded NASDAQ listed company focused on antibodies for research and diagnostics markets.

Managed sales and customer service for this private catalog antibody and molecular biology kit company.

Commercialized new genetic models, including transgenics and knock-outs, to biomedical research accounts. Built initial sales organization for this 75-year-old non-profit research institution.

Leader of marketing, sales, customer service, and administration functions for this provider of pre-clinical toxicology products and services.

Served as a Director and Secretary of the Chemical Marketing Research Association (1984-1988).

Commercialized specialty silicates in semiconductor manufacturing and remediation industries.

Developed and then commercially supported diagnostic reagents sold to clinical laboratories.

Studied the role of phospholipids in the mechanism-of-action of digoxin.